相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。ACOG Practice Bulletin No. 109: Cervical Cytology Screening
OBSTETRICS AND GYNECOLOGY (2014)
Validation of serum biomarkers for detection of early- and late-stage endometrial cancer
Gina Farias-Eisner et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2010)
Serum Amyloid A A Novel Biomarker for Endometrial Cancer
Emiliano Cocco et al.
CANCER (2010)
A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics
Hisashi Narimatsu et al.
FEBS JOURNAL (2010)
Identification of potential serum markers for endometrial cancer using protein expression profiling
Masashi Takano et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Assessing Lead Time of Selected Ovarian Cancer Biomarkers: A Nested Case-Control Study
Garnet L. Anderson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Validation of serum biomarkers for detection of early-stage ovarian cancer
Vladimir Nosov et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2009)
Serum YKL-40 as a marker for cervical adenocarcinoma
A. Mitsuhashi et al.
ANNALS OF ONCOLOGY (2009)
Serum amyloid A (SAA): a novel biomarker for uterine serous papillary cancer
E. Cocco et al.
BRITISH JOURNAL OF CANCER (2009)
HE4 as a biomarker for ovarian and endometrial cancer management
Jinping Li et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2009)
Screening for Ovarian Cancer
Daniel L. Clarke-Pearson
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
Vladimir Nossov et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Diagnostic markers for early detection of ovarian cancer
Irene Visintin et al.
CLINICAL CANCER RESEARCH (2008)
Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus
Richard G. Moore et al.
GYNECOLOGIC ONCOLOGY (2008)
Evaluation of serum amyloid A as a biomarker for gastric cancer
De-Chuan Chan et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Early ovarian cancer: 3-D power Doppler
S. Kupesic et al.
ABDOMINAL IMAGING (2006)
Serum proteomic features for detection of endometrial cancer
LR Zhu et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Serum vascular endothelial growth factor C (VEGF-C) as a specific biomarker for advanced cervical cancer: Relationship to insulin-like growth factor II (IGF-II), IGF binding protein 3 (IGF-BP3) and VEGF-B
SP Mathur et al.
GYNECOLOGIC ONCOLOGY (2005)
Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer
Z Zhang et al.
CANCER RESEARCH (2004)
Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma
N Khan et al.
CANCER (2004)
Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling
WCS Cho et al.
CLINICAL CANCER RESEARCH (2004)
Serum tumor markers in the management of ovarian, endometrial and cervical cancer
A Gadducci et al.
BIOMEDICINE & PHARMACOTHERAPY (2004)
Specific keynote: Ovarian cancer risk assessment and the potential for early detection
N Urban
GYNECOLOGIC ONCOLOGY (2003)
Assessment of cervical cancer radioresponse by serum squamous cell carcinoma antigen and magnetic resonance imaging
K Ohara et al.
OBSTETRICS AND GYNECOLOGY (2002)
Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer?
CH Hsieh et al.
GYNECOLOGIC ONCOLOGY (2002)
Tissue and serum CA125 expression in endometrial cancer
S Ginath et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2002)
Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix
M Takeda et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2002)
Serum vascular endothelial growth factor and serum leptin in patients with cervical cancer
A Lebrecht et al.
GYNECOLOGIC ONCOLOGY (2002)
Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment
E Pras et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Clinical value of thymidine kinase in patients with cervical carcinoma
R Fujiwaki et al.
ONCOLOGY (2001)
Serum CYFRA 21-1 in cervical cancer patients treated with radiation therapy
Y Suzuki et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2000)
Can initial serum Cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
KN Gaarenstroom et al.
GYNECOLOGIC ONCOLOGY (2000)
分享论文
